# A Bioavailability Study Comparing 3 Different AZD1981 Tablets

> **NCT01311635** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD1981, current small-particle tablet
- **DRUG:** AZD1981, new small-particle tablet
- **DRUG:** AZD1981, new large-particle table

## Key facts

- **NCT ID:** NCT01311635
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311635, "A Bioavailability Study Comparing 3 Different AZD1981 Tablets". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01311635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*